US312 — Staten Island, New York

US312 is a clinical research site located in Staten Island, New York, United States.

Crixeo Health Trust Score: 53/100 (POOR). This profile has not yet been claimed by the site owner.

US312 has participated in 2 clinical trials.

Therapeutic areas: Alzheimer's Disease.

Sponsors: H. Lundbeck A/S.

Sponsor Feasibility Report

Trust Score: 53/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for US312?

US312 has a Crixeo Trust Score of 53/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has US312 conducted?

US312 has 2 clinical trials on record. Their work covers Alzheimer's Disease.

Is US312 accredited by Crixeo Health?

US312 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about US312?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.